电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Enrofloxacin,Ciprofloxacin 抗体

This 小鼠 单克隆 antibody specifically detects Enrofloxacin,Ciprofloxacin in EIA. It exhibits reactivity toward Campylobacter.
产品编号 ABIN111400
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Enrofloxacin,Ciprofloxacin 抗体 (ABIN111400)

抗原

Enrofloxacin,Ciprofloxacin

适用

Campylobacter

宿主

  • 1
小鼠

克隆类型

  • 1
单克隆

标记

  • 1
非结合性

应用范围

Enzyme Immunoassay (EIA)

克隆位点

72FIG1F7#1
  • 纯化方法

    Purified

    免疫原

    Enrofloxacin conjugated to KLH (keyhole limpet hemocyanin) via carbodiimide

    亚型

    IgM
  • 应用备注

    Suitable for use in ELISA.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    限制

    仅限研究用
  • 浓度

    1.0 mg/mL (OD280 nm)

    缓冲液

    PBS buffer, pH 7.4 without preservatives

    储存液

    Without preservative

    注意事项

    Avoid repeated freezing and thawing.

    储存条件

    4 °C/-20 °C

    储存方法

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • 抗原

    Enrofloxacin,Ciprofloxacin

    背景

    Enrofloxacin is a fluoroquinolone that inhibits the activity of bacterial DNA gyrase. It was the first fluoroquinolone antimicrobial to be used in veterinary infections by E. coli, Salmonella, Pasteurella, Mycoplasma and Hemophilus species. Ciprofloxacin, a fluoroquinolone, is a concentration dependent bactericidal agent. It is structurally related to enrofloxacin, and has a similar spectrum of activity. Both of these antimicrobials have shown activity against some gram positive aerobes and a wide range of gram negative bacilli and cocci, which include Klebsiella, Pseudomonas, Salmonella, and other organisms such as Mycoplasma, Staphylococci and Chlamydia. Due to the fluoroquinolone's variable activity against most Streptococci, as well as their weak activity against many anaerobic bacteria, they are generally not recommended for use in treating infections where these types of microbes are present. Like enrofloxacin, ciprofloxacin is believed to act by inhibiting bacterial DNA gyrase which prevents DNA supercoiling and DNA synthesis.
You are here: